Paul E. Cayer
Net Worth
Last updated:
What is Paul E. Cayer net worth?
The estimated net worth of Mr. Paul E. Cayer is at least $5,882,364 as of 28 Mar 2022. He owns shares worth $24,605 as insider, has earned $23,159 from insider trading and has received compensation worth at least $5,834,600 in Otonomy, Inc..
What is the salary of Paul E. Cayer?
Mr. Paul E. Cayer salary is $583,460 per year as Chief Financial & Bus. Officer in Otonomy, Inc..
How old is Paul E. Cayer?
Mr. Paul E. Cayer is 63 years old, born in 1962.
What stocks does Paul E. Cayer currently own?
As insider, Mr. Paul E. Cayer owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Otonomy, Inc. (OTIC) | Chief Financial & Bus. Officer | 223,787 | $0.11 | $24,605 |
What does Otonomy, Inc. do?
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Paul E. Cayer insider trading
Otonomy, Inc.
Mr. Paul E. Cayer has made 6 insider trades between 2015-2022, according to the Form 4 filled with the SEC. Most recently he sold 5,624 units of OTIC stock worth $13,571 on 28 Mar 2022.
The largest trade he's ever made was exercising 5,624 units of OTIC stock on 28 Mar 2022. As of 28 Mar 2022 he still owns at least 223,787 units of OTIC stock.
Otonomy key executives
Otonomy, Inc. executives and other stock owners filed with the SEC:
- Dr. David Allen Weber (65) Pres, Chief Executive Officer & Director
- Dr. Jay B. Lichter Ph.D. (63) Co-Founder & Independent Chairman
- Mr. Paul E. Cayer (63) Chief Financial & Bus. Officer
- Mr. Robert Michael Savel II (57) Chief Technical Officer